arrow
B

Bin Wang

fudan university
H指数:31
被引数:3,894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Overcoming Immunotolerance in Chronic Hepatitis B: Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor–Based Immunotherapy in Achieving Hepatitis B Surface Antigen Seroclearance

克服慢性乙型肝炎中的免疫耐受:基于粒细胞-巨噬细胞集落刺激因子的免疫疗法在实现乙型肝炎表面抗原血清清除中的疗效

MedComm
IF10.7
2026-04-050
OAAI
Spatial Segregation Within Dissolving Microneedle Patches Overcomes Antigenic Interference and Enables Potent Bivalent Influenza–RSV Vaccination in Mice

溶解型微针贴片内的空间分离克服了抗原干扰,并实现了在 mice 中的强效双价流感–RSV 疫苗接种

2025-12-010
OAAI
A comprehensive single-cell atlas of three centenarian cohorts unveils unique natural killer cell signatures and enhanced mutual interactions among peripheral immune cells

一项针对三个百岁老人队列的全面单细胞图谱揭示了独特的自然杀伤细胞特征以及外周免疫细胞之间增强的相互作用的。

2025-09-120
PREAI
A Phase II Random, Double-Blind, Placebo-Controlled Study of the Safety and Immunogenicity of a Recombinant G Protein-Based Respiratory Syncytial Virus Vaccine in Healthy Older Adults

一项关于重组G蛋白基呼吸道合胞病毒疫苗在健康老年人群中的安全性及免疫原性的随机、双盲、安慰剂对照的II期研究

2025-08-220
PRE
Immunogenicity and safety of a booster dose of the COVID-19 DNA vaccine in healthy adults aged 18 years and above: a single-center, randomized, observer-blind, placebo-controlled phase 2 trial

COVID-19 DNA疫苗加强针在18岁及以上健康成人中的免疫原性和安全性:一项单中心、随机、观察者盲法、安慰剂对照的II期试验

2025-05-250
OA
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial

COVID-19 DNA疫苗在健康成人和老年人中的免疫原性和安全性: 一项随机,观察者盲,安慰剂对照的2期试验

2025-01-260
OAAI